raremaprare-disease reference indexOrphadata 2026-06-23 · HPO 2026-09-01
ORPHA:519

Acute myeloid leukemia

Synonyms: AML · Acute myelogenous leukemia

Type
Clinical group
Group
Group of disorders
Age of onset
All ages
Status
active

A group of neoplasms arising from precursor cells committed to the myeloid cell-line differentiation. All of them are characterized by clonal expansion of myeloid blasts. They manifest by fever, pallor, anemia, hemorrhages and recurrent infections.

1

Names in Orphadata languages

12 of 12 languages
LangNameSynonyms
enAcute myeloid leukemiaAML · Acute myelogenous leukemia
frLeucémie aiguë myéloïdeAML · LAM · LANL · Leucémie aiguë myéloblastique
deLeukämie, akute myeloischeAML · Leukämie, akute nicht-lymphoblastische
esLeucemia mieloide agudaLMA · Leucemia mielógena aguda
itLeucemia mieloide acutaAML · Leucemia mielogena acuta
nlAcute myeloïde leukemieAML · Acute myelogene leukemie
ptLeucemia mielóide agudaAML · Leucemia mielogéna aguda
plOstra białaczka szpikowaAML · Ostra białaczka mielogeniczna
csAkutní myeloidní leukémieAML
ukГострий мієлоїдний лейкозГострий мієлогенний лейкоз · AML
zh急性髓性白血病急性髓性白血病
trAkut miyeloid lösemiAML · Akut miyelojenöz lösemi

Definition in:

2

Cross-references

qualifier = Orphanet mapping relation
SourceCodeQualifierICD relationValidation
OMIM601626Evalidated
ICD-10C92.0Especificvalidated
ICD-112A60Especificvalidated
MONDO0018874Evalidated
MONDO18874Evalidated
MeSHD015470Evalidated
UMLSC0023467Evalidated
GARD12757Evalidated
MedDRA10000880Evalidated

E exact · NTBT this ORPHAcode is narrower than the target · BTNT broader than the target · ND not decided.

3

Classification

Preferential parent (Orphanet linearisation):

Parents in the classifications (1):

Children (6):

4

Genes

0 direct

Orphanet records no gene directly on this code.

5

Prevalence and incidence

7 records
TypeClassValueAreaQualificationValidationSource
Annual incidence1-9 / 100 0002.5 / 100 000WorldwideValue and classValidated17019734[PMID]
Point prevalence1-5 / 10 00010 / 100 000EuropeValue and classValidatedEuropean Medicines Agency 2018[OTHER]
Annual incidence1-9 / 100 0003.39 / 100 000EuropeValue and classValidated22033323[PMID]_RARECARE surveillance of rare cancers in Europe[OTHER]
Lifetime Prevalence1-5 / 10 00010.98 / 100 000EuropeValue and classValidated22033323[PMID]_RARECARE surveillance of rare cancers in Europe[OTHER]
Annual incidence1-9 / 100 0004.4 / 100 000FranceValue and classValidatedOTHERitut National du Cancer 2013[OTHER]
Annual incidence1-9 / 100 0002.8 / 100 000DenmarkValue and classValidated24039451[PMID]
Annual incidence1-9 / 100 0003.7 / 100 000United StatesValue and classValidatedNational Cancer OTHERitute 2010[OTHER]

Value is Orphadata's ValMoy: the mean estimate per 100 000 for prevalence and incidence, the number of cases or families for case reports.

6

HPO phenotypes

Orphanet has no HPO annotation for this code in this release.

7

Sources for this card